OCUGEN
Live / Applied — Statement of use — registration review complete (as of 27 Mar 2026)
What this means for you
Not registered yet, but its 01 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98161654
- Mark type
- Design + words
- Filed
- 01 Sept 2023
- Published for opposition
- 21 Jan 2025
- Attorney of record
- Don Cha
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of pharmaceutical preparations; House mark for a full line of pharmaceutical preparations for vaccines and for treating diseases and disorders such as infections, eye disorders, and orthopedic diseases
Owner
- Ocugen, Inc., MALVERN, PA, US
- Ocugen, Inc., MALVERN, PA, US
Prior registrations
Prosecution history
- 27 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Sept 2025 — USE AMENDMENT FILED
- 26 Mar 2026 — SOU EXTENSION 1 GRANTED
- 17 Sept 2025 — SOU EXTENSION 1 FILED
- 23 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 19 Sept 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 19 Sept 2025 — NOTICE OF REVIVAL - E-MAILED
- 19 Sept 2025 — PETITION TO REVIVE-GRANTED
- 19 Sept 2025 — TEAS PETITION TO REVIVE RECEIVED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED